Safety and Efficacy of Adipose Derived Stem Cells in Refractory Rheumatoid Arthritis, Systemic Lupus Erythematosus or Sharp’s Syndrome March 6, 2020checkorphan Learn more about: Sharp syndrome Related Clinical Trial Safety and Efficacy of Adipose Derived Stem Cells in Refractory Rheumatoid Arthritis, Systemic Lupus Erythematosus or Sharp’s Syndrome Recruitment InformationAdministrative Informations